A new study published by theInternational Journal of Clinical Nutrition & Dietetics released in February 2019 demonstrates the effectiveness of a unique combination in preventing Alzheimer's disease. Although experts agree that the best way to keep your memory is to use it as often as possible, it seems that advances in research offer a glimmer of hope for slowing the symptoms.
Cognixtra, an effective treatment for the prevention of Alzheimer's disease?
While a number of scientific studies have demonstrated the importance ofnutritional approach to protect brain health, this new study confirms the efficacy of a daily administration of a unique omega-3 fatty acid and antioxidant complex (cogniXtra) as a neuroprotector of early Alzheimer's disease symptoms.
The research focused on the neuroprotective efficacy of docosahexaenoic acid (DHA), glutathione (GSH), phosphatidylcholine (PC), curcumin (CUR), and resveratrol (RES) administered alone or in combination for 30 consecutive days as a preventive treatment.
The cause of Alzheimer's disease is not fully elucidated, but it is widely understood to be the involvement of several processes, including amyloid beta peptide (Aβ)accumulation, oxidative stress, inflammation, and several biochemical pathways. The formation of extracellular Aβ deposits leads to the formation of neurofibrillary tangles and neuritic plaques in the cortex and hippocampus. Aβ-induced toxicity is affected by free radicals responsible for lipid peroxidation of neuronal cell membranes.
The results of the study clearly show the synergistic effect of the protective actions of long treatment of GSH/PC, CUR/RES, and DHA, on cognitive impairment and oxidative stress induced by Aβ25-35 injections in mice.
In other words, the study considers CogniXtra treatment to be a very valuable dietary supplement for the prevention of neurodegenerative diseases such as Alzheimer's disease.
Alzheimer's disease or the urgency to act
According to the National Institute of Health, if no change is seen in the coming years, the number of people suffering from the disease is expected to reach 131 million by 2050 worldwide, and the cost of care in the United States, which is currently more than $200 billion per year, will reach an alarming $1 trillion!
Alzheimer's disease (AD) is the most common form of dementia. It is characterized by a progressive loss of memory and the decline of other cognitive abilities affecting the daily lives of older adults and constituting one of the major health problems in the elderly.